July 26, 2016
Recommended Topic Related To:

Tnkase

"The U.S. Food and Drug Administration today approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary interventio"...

A A A

Tnkase




Overdosage
Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

TNKase (tenecteplase) therapy in patients with acute myocardial infarction is contraindicated in the following situations because of an increased risk of bleeding (see WARNINGS):

  • Active internal bleeding
  • History of cerebrovascular accident
  • Intracranial or intraspinal surgery or trauma within 2 months
  • Intracranial neoplasm, arteriovenous malformation,or aneurysm
  • Known bleeding diathesis
  • Severe uncontrolled hypertension
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/6/2008

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Heart Health

Get the latest treatment options.

Atrial Fibrillation Quiz